Product Images Venlafaxine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Venlafaxine Hydrochloride NDC 70518-2259 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Remedy_Label - Remedy Label
Venlafaxine HCI extended-release capsules in 150mg strength. This package contains 90 capsules with NDC number 70518-2259-00 and an expiration date, but no LOT number. The source NDC number is 65862-0697-90 and the manufacturer is Aurobindo Pharma. The medication should be kept out of reach of children and stored at temperatures between 20-26°C (63-77°F), with excursions permitted up to 15-30°C (59-86°F). For instructions on use, refer to the package insert. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA.*
Venlafaxine HCl 150mg 70518 2259 01
Venlafaxine HCI is an extended-release medication in the form of a 150mg capsule that comes in a quantity of 90. The medication is manufactured by Aurcbindo Pharma in Dayton, NJ, and is repackaged by RemedyRepack Inc. in Indiana, PA. The National Drug Code (NDC) is 70518-2259-01, and the source NDC is 65862-0697-05. There is no information on the expiry date or lot number provided. The medication should be stored at 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F) and kept out of the reach of children. Directions for use are available in the package insert.*
Venlafaxine HCl 150mg 70518 2259 02
Venlafaxine HCI Extended-Release 150mg Capsules, packaged by RemedyRepack Inc., contain 30 capsules with an NDC number 70518-2259-02. This medication is manufactured by Aurcbindo Pharma and should be stored between 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F). The directions for use should be followed as stated in the package insert. No expiration date and lot number are provided in the text. Keep this medicine out of the reach of children.*
Venlafaxine HCl 150mg 70518 2259 03
Venlafaxine HCI is a medication available in the form of extended-release capsules with a strength of 150 mg. The package contains 30 capsules with an NDC number of 70518-2259-03 and should be stored at a temperature between 20-26°C (63-77°F). The product has been repackaged by RemedyRepack Inc. in Indiana, PA, and its source NDC is 65862-0697-90. The capsule is manufactured by Aurcbindo Pharma in Dayton, NJ. The information does not specify the expiry date or lot number. The package insert should be referred to for directions on usage.*
Venlafaxine HCl 150mg 70518 2259 04
Venlafaxine HCI is an extended-release medication in the form of 150 mg capsules. Each bottle contains 30 capsules and has an NDC number of 70518-2259-04. There is no specified expiration date or lot number. It is manufactured by Aurobindo Pharma and distributed by Source NDC 65862-0697-05. It is recommended to keep this medication out of the reach of children and to store it between 20-26°C (63-77°F) with permissible excursions from 15-30°C (59-86°F). This specific bottle has been repackaged by RemedyRepack Inc. in Indiana. The package insert should be referred to for directions on use.*
Figure 1: Effect of interacting drugs on the pharmacokinetics of venlafaxine and active metabolite O-desmethylvenlafaxine (ODV). - venlafaxine fig1
Description not available.*
Figure 2: Effect of venlafaxine on the pharmacokinetics interacting drugs and their active metabolites. - venlafaxine fig2
Figure 3: Pharmacokinetics of venlafaxine and its metabolite O-desmethylvenlafaxine (ODV) in special populations. - venlafaxine fig3
Chemical Structure - venlafaxine str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.